e13 5 embryos Search Results


embryonic day e13.5 embryos  (Charles River Laboratories)
90
Charles River Laboratories embryonic day e13.5 embryos
Embryonic Day E13.5 Embryos, supplied by Charles River Laboratories, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/embryonic day e13.5 embryos/product/Charles River Laboratories
Average 90 stars, based on 1 article reviews
embryonic day e13.5 embryos - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
e13.5 embryos  (Harlan Sprague Dawley)
90
Harlan Sprague Dawley e13.5 embryos
E13.5 Embryos, supplied by Harlan Sprague Dawley, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/e13.5 embryos/product/Harlan Sprague Dawley
Average 90 stars, based on 1 article reviews
e13.5 embryos - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
primary mouse embryo fibroblast (mefs) at e13.5 stage  (Harlan Laboratories)
90
Harlan Laboratories primary mouse embryo fibroblast (mefs) at e13.5 stage
Primary Mouse Embryo Fibroblast (Mefs) At E13.5 Stage, supplied by Harlan Laboratories, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/primary mouse embryo fibroblast (mefs) at e13.5 stage/product/Harlan Laboratories
Average 90 stars, based on 1 article reviews
primary mouse embryo fibroblast (mefs) at e13.5 stage - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
a pool of atrial tissues from 57 e13.5 c57bl/6j mouse embryos  (Active Motif)
90
Active Motif a pool of atrial tissues from 57 e13.5 c57bl/6j mouse embryos
A Pool Of Atrial Tissues From 57 E13.5 C57bl/6j Mouse Embryos, supplied by Active Motif, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/a pool of atrial tissues from 57 e13.5 c57bl/6j mouse embryos/product/Active Motif
Average 90 stars, based on 1 article reviews
a pool of atrial tissues from 57 e13.5 c57bl/6j mouse embryos - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
microglial cultures derived from e13.5 mouse embryos  (Janvier Labs)
90
Janvier Labs microglial cultures derived from e13.5 mouse embryos
<t>Microglial</t> cells were incubated with three different doses of JN403 (100 nM, 1 μM, and 10 μM) for 24 hours, followed by an assessment of cell viability using the MTT-assay. (A) JN403 treatment alone did not elicit cellular toxicity in microglial cells at concentrations up to 1 μM. non-significant (n.s). (B) Microglial cells were pre-treated with 100 nM or 1 μM of JN403 for 24 hours and additionally coincubated for another 24 hours with 1μM αSyn fragment 61-140 on the next day. αSyn induced cytotoxicity in microglial cells. Neither 100 nM nor 1 μM of JN403 treatment changed the cell viability. Data are presented as the mean ± standard error of the mean. Cell viability was measured for multiple independent experiments. **** p < 0.0001, significantly different from the control group.
Microglial Cultures Derived From E13.5 Mouse Embryos, supplied by Janvier Labs, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/microglial cultures derived from e13.5 mouse embryos/product/Janvier Labs
Average 90 stars, based on 1 article reviews
microglial cultures derived from e13.5 mouse embryos - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
animals e13.5 embryos from timed pregnant hsd:nsa (cf-1) mice  (Envigo)
90
Envigo animals e13.5 embryos from timed pregnant hsd:nsa (cf-1) mice
<t>Microglial</t> cells were incubated with three different doses of JN403 (100 nM, 1 μM, and 10 μM) for 24 hours, followed by an assessment of cell viability using the MTT-assay. (A) JN403 treatment alone did not elicit cellular toxicity in microglial cells at concentrations up to 1 μM. non-significant (n.s). (B) Microglial cells were pre-treated with 100 nM or 1 μM of JN403 for 24 hours and additionally coincubated for another 24 hours with 1μM αSyn fragment 61-140 on the next day. αSyn induced cytotoxicity in microglial cells. Neither 100 nM nor 1 μM of JN403 treatment changed the cell viability. Data are presented as the mean ± standard error of the mean. Cell viability was measured for multiple independent experiments. **** p < 0.0001, significantly different from the control group.
Animals E13.5 Embryos From Timed Pregnant Hsd:Nsa (Cf 1) Mice, supplied by Envigo, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/animals e13.5 embryos from timed pregnant hsd:nsa (cf-1) mice/product/Envigo
Average 90 stars, based on 1 article reviews
animals e13.5 embryos from timed pregnant hsd:nsa (cf-1) mice - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

Image Search Results


Microglial cells were incubated with three different doses of JN403 (100 nM, 1 μM, and 10 μM) for 24 hours, followed by an assessment of cell viability using the MTT-assay. (A) JN403 treatment alone did not elicit cellular toxicity in microglial cells at concentrations up to 1 μM. non-significant (n.s). (B) Microglial cells were pre-treated with 100 nM or 1 μM of JN403 for 24 hours and additionally coincubated for another 24 hours with 1μM αSyn fragment 61-140 on the next day. αSyn induced cytotoxicity in microglial cells. Neither 100 nM nor 1 μM of JN403 treatment changed the cell viability. Data are presented as the mean ± standard error of the mean. Cell viability was measured for multiple independent experiments. **** p < 0.0001, significantly different from the control group.

Journal: bioRxiv

Article Title: JN403, an alpha-7-nicotine-acetylcholine-receptor agonist, reduces alpha-synuclein induced inflammatory parameters of in vitro microglia but fails to attenuate the reduction of TH positive nigral neurons in a focal alpha-synuclein overexpression mouse model of Parkinson’s disease

doi: 10.1101/2020.04.04.996892

Figure Lengend Snippet: Microglial cells were incubated with three different doses of JN403 (100 nM, 1 μM, and 10 μM) for 24 hours, followed by an assessment of cell viability using the MTT-assay. (A) JN403 treatment alone did not elicit cellular toxicity in microglial cells at concentrations up to 1 μM. non-significant (n.s). (B) Microglial cells were pre-treated with 100 nM or 1 μM of JN403 for 24 hours and additionally coincubated for another 24 hours with 1μM αSyn fragment 61-140 on the next day. αSyn induced cytotoxicity in microglial cells. Neither 100 nM nor 1 μM of JN403 treatment changed the cell viability. Data are presented as the mean ± standard error of the mean. Cell viability was measured for multiple independent experiments. **** p < 0.0001, significantly different from the control group.

Article Snippet: Briefly, microglial cultures derived from E13.5 mouse embryos (Janvier Breeding Center, France) were obtained by mild trypsinization as described previously.

Techniques: Incubation, MTT Assay, Control

Inflammatory parameters (A) Nitric Oxide (NO) and (B) TNF-α were measured in JN403 pre-treated microglial cells for a baseline. (A) NO, and (B) TNF-α release increased with 1μM αSyn incubation, but both 100 nM and 1 μM of JN403 co-treatment significantly reduced NO and TNF-α release, * p < 0.05, ** p < 0.01.

Journal: bioRxiv

Article Title: JN403, an alpha-7-nicotine-acetylcholine-receptor agonist, reduces alpha-synuclein induced inflammatory parameters of in vitro microglia but fails to attenuate the reduction of TH positive nigral neurons in a focal alpha-synuclein overexpression mouse model of Parkinson’s disease

doi: 10.1101/2020.04.04.996892

Figure Lengend Snippet: Inflammatory parameters (A) Nitric Oxide (NO) and (B) TNF-α were measured in JN403 pre-treated microglial cells for a baseline. (A) NO, and (B) TNF-α release increased with 1μM αSyn incubation, but both 100 nM and 1 μM of JN403 co-treatment significantly reduced NO and TNF-α release, * p < 0.05, ** p < 0.01.

Article Snippet: Briefly, microglial cultures derived from E13.5 mouse embryos (Janvier Breeding Center, France) were obtained by mild trypsinization as described previously.

Techniques: Incubation

Iba1+ microglial cells were detected and the density analysis showed no differences between the rAAV groups and treatment groups. (A) Representative photomicrographs showing Iba1+ signals per group, TH (green) and Iba1 (magenta). No activated forms of microglia were found. Scale bar 200 μm. (B) The ratio of Iba1+ density of the injected side compared to the non-injected side showed no significant differences between the rAAVs and treatment, n=4, non-significant (n.s).

Journal: bioRxiv

Article Title: JN403, an alpha-7-nicotine-acetylcholine-receptor agonist, reduces alpha-synuclein induced inflammatory parameters of in vitro microglia but fails to attenuate the reduction of TH positive nigral neurons in a focal alpha-synuclein overexpression mouse model of Parkinson’s disease

doi: 10.1101/2020.04.04.996892

Figure Lengend Snippet: Iba1+ microglial cells were detected and the density analysis showed no differences between the rAAV groups and treatment groups. (A) Representative photomicrographs showing Iba1+ signals per group, TH (green) and Iba1 (magenta). No activated forms of microglia were found. Scale bar 200 μm. (B) The ratio of Iba1+ density of the injected side compared to the non-injected side showed no significant differences between the rAAVs and treatment, n=4, non-significant (n.s).

Article Snippet: Briefly, microglial cultures derived from E13.5 mouse embryos (Janvier Breeding Center, France) were obtained by mild trypsinization as described previously.

Techniques: Injection